Glucagon Market Size, Share & COVID-19 Impact Analysis, By Route of Administration (Injectable and Inhalation), By Application (Hypoglycemia and Diagnostic Aid), By Distribution Channel (Hospital Pharmacies, Drug Stores & Retail Pharmacies, and Online Pharmacies), and Regional Forecast, 2023-2030

ATTRIBUTE

DETAILS

Study Period

2017-2030

Base Year

2022

Estimated Year

2023

Forecast Period

2023-2030

Historical Period

2017-2021

Growth Rate

CAGR of 6.8% from 2023 to 2030

Unit

Value (USD Million),  Volume (1,000 Units)

Segmentation

By Route of Administration

• Injectable
• Inhalation

By Application

• Hypoglycemia
• Diagnostic Aid

By Distribution Channel

• Hospital Pharmacies
• Drug Stores & Retail Pharmacies
• Online Pharmacies

By Region

• North America (By Route of Administration, Application, Distribution Channel, and Country)
  • U.S.
  • Canada
• Europe (By Route of Administration, Application, Distribution Channel, and Country/ Sub-Region)
  • U.K.
  • Germany
  • France
  • Italy
  • Spain
  • Scandinavia
  • Rest of Europe
• Asia Pacific (By Route of Administration, Application, Distribution Channel, and Country/ Sub-Region)
  • Japan
  • China
  • India
  • Australia
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America (By Route of Administration, Application, Distribution Channel, and Country/ Sub-Region)
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa (By Route of Administration, Application, Distribution Channel, and Country/ Sub-Region)
  • GCC
  • South Africa
  • Rest of the Middle East & Africa